Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort

MLA

Eyad Abu-Isa, et al. “Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.” International Journal of Radiation Oncology*Biology*Physics, vol. 112, Mar. 2022, pp. 853–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70b907b164dd3b79de5a0f014f4cc83d&authtype=sso&custid=ns315887.

APA

Eyad Abu-Isa, Frank A. Vicini, Eleanor M. Walker, Peter Paximadis, Isaac Kaufman, D P Bergsma, David K. Heimburger, Michael M. Dominello, Jeffrey D. Radawski, Amit Bhatt, Lori J. Pierce, Paul G. Kocheril, Annette E. Kretzler, Kent A. Griffith, Stephen Franklin, Joshua T. Dilworth, & Reshma Jagsi. (2022). Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort. International Journal of Radiation Oncology*Biology*Physics, 112, 853–860.

Chicago

Eyad Abu-Isa, Frank A. Vicini, Eleanor M. Walker, Peter Paximadis, Isaac Kaufman, D P Bergsma, David K. Heimburger, et al. 2022. “Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.” International Journal of Radiation Oncology*Biology*Physics 112 (March): 853–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70b907b164dd3b79de5a0f014f4cc83d&authtype=sso&custid=ns315887.